REGULATION OF KETO ACID DEHYDROGENSES IN THE HEART

心脏中酮酸脱氢的调节

基本信息

  • 批准号:
    3337792
  • 负责人:
  • 金额:
    $ 14.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1979
  • 资助国家:
    美国
  • 起止时间:
    1979-08-01 至 1990-06-30
  • 项目状态:
    已结题

项目摘要

The major objective of the proposed research program is to elucidate regulatory mechanisms for two multienzyme complexes involved in mirochondrial energy production in cardiac tissue. The regulation of the pyruvate and the branched chain Alpha-keto acid dehydrogenase enzyme complexes by two forms of covalent modification (e.g., phosphorylation and acylation) will be investigated using the purified enzyme complexes from bovine heart, isolated rat heart mitochondria and in the isolated perfused rat heart. Experimental support will be sought for our contention that these two enzyme complexes are activated by their respective natural substrates but inactivated by the substrates for the other complex, e.g., pyruvate activates pyruvate dehydrogenase but inactivate the branched chain complex while the branched chain Alpha-keto acids activate the branched chain complex but inactivate the pyruvate complex. Of particular interest will be our suggestion that the pyruvate dehydrogenase kinase may be regulated by acylation/acetylation by various Alpha-keto acid substrates or Coenzyme A derivatives. Finally, the effects of various metabolic and hormonal states on the regulation of the pyruvate and branched chain dehydrogenase complexes will be investigated in perfused heart preparations. Experiments are proposed to test a suggestion that insulin exerts its stimulatory effect on the pyruvate dehydrogenase complex through an effect of a (e.g., disulfide containing) mediator substance on a reactive thiol moiety on the pyruvate dehydrogenase kinase. It is anticipated that the proposed studies will provide a necessary and unique perception of how the regulation of these two very important enzyme complexes is crucial for the maintenance of an appropriate energy generating capability in my myocardium.
提出的研究计划的主要目的是阐明

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MERLE S OLSON其他文献

MERLE S OLSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MERLE S OLSON', 18)}}的其他基金

AGEPC--A POTENT LIPID BIOCHEMICAL MEDIATOR IN LIVER
AGEPC--肝脏中有效的脂质生化介质
  • 批准号:
    2712030
  • 财政年份:
    1997
  • 资助金额:
    $ 14.51万
  • 项目类别:
SMALL INSTRUMENTATION PROGRAM
小型仪器项目
  • 批准号:
    3524066
  • 财政年份:
    1989
  • 资助金额:
    $ 14.51万
  • 项目类别:
AGEPC--A POTENT LIPID BIOCHEMICAL MEDIATOR IN LIVER
AGEPC--肝脏中有效的脂质生化介质
  • 批准号:
    2139097
  • 财政年份:
    1984
  • 资助金额:
    $ 14.51万
  • 项目类别:
AGEPC--A POTENT LIPID BIOCHEMICAL MEDIATOR IN LIVER
AGEPC--肝脏中有效的脂质生化介质
  • 批准号:
    2139096
  • 财政年份:
    1984
  • 资助金额:
    $ 14.51万
  • 项目类别:
AGEPC--A POTENT LIPID BIOCHEMICAL MEDIATOR IN LIVER
AGEPC--肝脏中有效的脂质生化介质
  • 批准号:
    2139098
  • 财政年份:
    1984
  • 资助金额:
    $ 14.51万
  • 项目类别:
AGEPC--A POTENT LIPID BIOCHEMICAL MEDIATOR IN LIVER
AGEPC--肝脏中有效的脂质生化介质
  • 批准号:
    2391358
  • 财政年份:
    1984
  • 资助金额:
    $ 14.51万
  • 项目类别:
BIOENERGETIC REGULATION AND NEUROLOGICAL MATURATION
生物能量调节和神经成熟
  • 批准号:
    3399473
  • 财政年份:
    1983
  • 资助金额:
    $ 14.51万
  • 项目类别:
REGULATION OF KETO ACID DEHYDROGENSES IN THE HEART
心脏中酮酸脱氢的调节
  • 批准号:
    3337796
  • 财政年份:
    1979
  • 资助金额:
    $ 14.51万
  • 项目类别:
REGULATION OF KETO ACID DEHYDROGENSES IN THE HEART
心脏中酮酸脱氢的调节
  • 批准号:
    3337797
  • 财政年份:
    1979
  • 资助金额:
    $ 14.51万
  • 项目类别:
REGULATION OF KETO ACID DEHYDROGENSES IN THE HEART
心脏中酮酸脱氢的调节
  • 批准号:
    3337798
  • 财政年份:
    1979
  • 资助金额:
    $ 14.51万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 14.51万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 14.51万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 14.51万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 14.51万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 14.51万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 14.51万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 14.51万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 14.51万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 14.51万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 14.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了